Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The North America endometriosis market was valued at USD 800.87 Million in 2025 and is expected to grow at a CAGR of 10.10%, reaching USD 2096.21 Million by 2035. The market growth is driven by growing awareness of endometriosis, advancements in diagnostic tools, and rising demand for targeted therapies.
Base Year
Historical Period
Forecast Period
In the United States, around 6.5 million women are reported to suffer from endometriosis. This rising burden of the disease is expected to directly impact the market demand for effective treatment options and advanced diagnostic methods.
One of the major North America endometriosis market trends is the rise in merger and acquisition activities. For example, in January 2024, Hera Biotech, Inc., acquired Scailyte AG to expedite the development of non-invasive clinical diagnostic tests for endometriosis.
Increased research funding for endometriosis and heightened patient awareness are influencing the market share.
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Abbott Laboratories
This American multinational healthcare company is known for its drug Elagolix (the first oral gonadotropin-releasing hormone antagonist that entered clinical development and was granted regulatory approval to manage endometriosis), developed in collaboration with an American biopharmaceutical company Neurocrine Biosciences, Inc.
Teva Pharmaceuticals Industries Ltd.
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company specializing primarily in generic drugs. It has a robust generic women’s health portfolio and invests heavily in pharmaceutical products aimed at improving women's reproductive health.
Sun Pharmaceutical Industries Ltd.
Sun Pharma is a prominent global specialty generic pharmaceutical company. The company sells Leuprolide injection (Lupron Depot) which is used alone or in combination with other drugs such as norethindrone to treat endometriosis.
Sanofi S.A.
Sanofi S.A. is a French multinational pharmaceutical and healthcare company. Its drug asset Danazol is a pituitary gonadotropin inhibitor used in the treatment of endometriosis.
Other players in the market include AbbVie, Inc., AstraZeneca PLC, Pfizer, Inc., Merck & Co., Inc., GlaxoSmithKline PLC, and Consilient Health Limited.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market is anticipated to grow at a CAGR of 10.10% during the forecast period of 2026-2035, driven by the increasing prevalence of endometriosis in the region.
The rising investment in endometriosis research and advancements in diagnostic technologies are fuelling the demand for the market.
One of the significant trends in the market is the rise in strategic partnerships among the key players. For example, in January 2024 , Hera Biotech, Inc., acquired Scailyte AG to expedite the development of non-invasive clinical diagnostic tests for endometriosis.
Based on the drug, the market is segmented into oral contraceptives, progestins, NSAIDS, GnRH analogues, and LNR-IUDs, among others.
By type, the market is divided into superficial peritoneal endometriosis, endometriomas, and deeply infiltrating endometriosis, among others.
The market breakup by treatment type includes hormonal therapy, and pain management, among others.
End users of the market are hospitals and specialty clinics, among others.
Major distribution channels of the market include hospital pharmacies, retail pharmacies, drugstores, and E-commerce, among others.
The market segmentation by countries includes the United States of America and Canada.
The key players in the market are Abbott Laboratories, Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., Sanofi S.A., AbbVie, Inc., AstraZeneca PLC, Pfizer, Inc., Merck & Co., Inc., GlaxoSmithKline PLC, and Consilient Health Limited.
Datasheet
One User
USD 2,699
USD 2,429
tax inclusive*
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.